Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francesco Franchi

Showing results (81-90 of 147) with videos related to

Pageof 15
Sort By:
BMJ Open Diabetes Research & Care|February 27, 2021
Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover studyFrancesco Franchi, Dmitry M Yaranov, Fabiana Rollini, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 14, 2021
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trialsLuis Ortega-Paz, Mattia Galli, Davide Capodanno, et al.
Journal of Cardiovascular Translational Research|December 21, 2013
Impact of cigarette smoking on P2Y12 receptor binding activity before and after clopidogrel therapy in patients with coronary artery diseaseJung Rae Cho, Bhaloo Desai, Michael J Haas, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 16, 2024
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysisMattia Galli, Giovanni Occhipinti, Stefano Benenati, et al.
Journal of Thrombosis and Thrombolysis|August 18, 2014
Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonistsFrancesco Franchi, Jafri Syed Hammad, Fabiana Rollini, et al.
Circulation|August 26, 2016
Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 StudyFrancesco Franchi, Fabiana Rollini, Niti Aggarwal, et al.
Thrombosis and Haemostasis|July 26, 2013
Impact of aspirin dose on adenosine diphosphate-mediated platelet activities. Results of an in vitro pilot investigationAntonio Tello-Montoliu, Estela Thano, Fabiana Rollini, et al.
Circulation|October 12, 2020
Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 StudyFrancesco Franchi, Fabiana Rollini, Latonya Been, et al.
Journal of Translational Medicine|April 13, 2018
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary interventionLarisa H Cavallari, Francesco Franchi, Fabiana Rollini, et al.
Thrombosis and Haemostasis|October 28, 2016
Impact of chronic kidney disease on platelet P2Y<sub>12</sub> receptor signalling in patients with type 2 diabetes mellitusLydia R Engwenyu, Francesco Franchi, Fabiana Rollini, et al.
Pageof 15

Showing results (81-90 of 147) with videos related to

Sort By:
Pageof 15
BMJ Open Diabetes Research & Care|February 27, 2021
Effects of D-allulose on glucose tolerance and insulin response to a standard oral sucrose load: results of a prospective, randomized, crossover studyFrancesco Franchi, Dmitry M Yaranov, Fabiana Rollini, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|September 14, 2021
Safety and efficacy of different prophylactic anticoagulation dosing regimens in critically and non-critically ill patients with COVID-19: a systematic review and meta-analysis of randomized controlled trialsLuis Ortega-Paz, Mattia Galli, Davide Capodanno, et al.
Journal of Cardiovascular Translational Research|December 21, 2013
Impact of cigarette smoking on P2Y12 receptor binding activity before and after clopidogrel therapy in patients with coronary artery diseaseJung Rae Cho, Bhaloo Desai, Michael J Haas, et al.
European Heart Journal. Cardiovascular Pharmacotherapy|May 16, 2024
Comparative effects of different antiplatelet strategies in carriers of CYP2C19 loss-of-function alleles: a network meta-analysisMattia Galli, Giovanni Occhipinti, Stefano Benenati, et al.
Journal of Thrombosis and Thrombolysis|August 18, 2014
Role of thromboelastography and rapid thromboelastography to assess the pharmacodynamic effects of vitamin K antagonistsFrancesco Franchi, Jafri Syed Hammad, Fabiana Rollini, et al.
Circulation|August 26, 2016
Pharmacodynamic Comparison of Prasugrel Versus Ticagrelor in Patients With Type 2 Diabetes Mellitus and Coronary Artery Disease: The OPTIMUS (Optimizing Antiplatelet Therapy in Diabetes Mellitus)-4 StudyFrancesco Franchi, Fabiana Rollini, Niti Aggarwal, et al.
Thrombosis and Haemostasis|July 26, 2013
Impact of aspirin dose on adenosine diphosphate-mediated platelet activities. Results of an in vitro pilot investigationAntonio Tello-Montoliu, Estela Thano, Fabiana Rollini, et al.
Circulation|October 12, 2020
Pharmacodynamic and Pharmacokinetic Effects of a Low Maintenance Dose Ticagrelor Regimen Versus Standard Dose Clopidogrel in Diabetes Mellitus Patients Without Previous Major Cardiovascular Events Undergoing Elective Percutaneous Coronary Intervention: The OPTIMUS-6 StudyFrancesco Franchi, Fabiana Rollini, Latonya Been, et al.
Journal of Translational Medicine|April 13, 2018
Clinical implementation of rapid CYP2C19 genotyping to guide antiplatelet therapy after percutaneous coronary interventionLarisa H Cavallari, Francesco Franchi, Fabiana Rollini, et al.
Thrombosis and Haemostasis|October 28, 2016
Impact of chronic kidney disease on platelet P2Y<sub>12</sub> receptor signalling in patients with type 2 diabetes mellitusLydia R Engwenyu, Francesco Franchi, Fabiana Rollini, et al.
Pageof 15